Author: Sean Williams, The Motley Fool

The company isn’t close to being profitable, yet it profiles as possibly the most expensive megacap stock on Wall Street.

A 10% drawdown in Wall Street’s iconic stock index means that bargains abound for patient investors.

It’s valuation is more attractive than it’s ever been.

These brand-name companies with high-octane dividend yields can pad the pocketbooks of patient investors.

A new apple caught the Oracle of Omaha’s eye before his retirement – and it has soared around 6,700%, including dividends, since its IPO.